Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
DOC-1021 by Diakonos Oncology for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
DOC-1021 is under clinical development by Diakonos Oncology and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According to GlobalData,...
Data Insights
DOC-1021 by Diakonos Oncology for Glioblastoma Multiforme (GBM): Likelihood of Approval
DOC-1021 is under clinical development by Diakonos Oncology and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData,...